Released May 10, 2016, after the close
10-Q filed May 10, 2016, 40 days after period end · 0001390478-16-000110
Q1 2016 · 10-Q
Revenue—
Net Income-$16.49M-$16.49M N/M vs Q1 2015N/M vs Q4 2015
EPS, diluted—
Operating Income-$8,968,000N/M
Operating Cash Flow-$13,216,000N/M
Free Cash Flowderived-$13,222,000N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | — | $2.75M | $2.17M | $2.75M |
| Net Income | -$16.49M | -$10.54M | -$2.54M | -$16.49M |
| EPS Diluted | — | -$0.08 | -$0.02 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR